16 HOW SUPPLIED/STORAGE AND HANDLING
Safety and Handling Instructions
Access to drugs with a potential for abuse such as Hydromorphone Hydrochloride Injection presents an occupational hazard for addiction in the health care industry. Routine procedures for handling controlled substances developed to protect the public may not be adequate to protect health care workers. Implementation of more effective accounting procedures and measures to restrict access to drugs of this class (appropriate to the practice setting) may minimize the risk of self-administration by health care providers.
How Supplied
Hydromorphone Hydrochloride Injection is supplied as a sterile solution in single‑dose NexJectTM prefilled syringes for intravenous, intramuscular, and subcutaneous administration, and available as follows:
Unit of Sale | Concentration (per total volume) |
---|
NDC 0409-1805-01 Clamshell of 10 0.5 mL fill in 1.5 mL NexJect™ Single-dose Prefilled Syringe with Luer Lock | 0.25 mg/0.5 mL |
NDC 0409-4264-01 Clamshell of 10 0.5 mL fill in 1.5 mL NexJect™ Single-dose Prefilled Syringe with Luer Lock | 0.5 mg/0.5 mL |
NDC 0409-1283-37 Clamshell of 10 1 mL fill in 1.5 mL NexJect™ Single-dose Prefilled Syringe with Luer Lock | 1 mg/mL |
NDC 0409-1312-36 Clamshell of 10 1 mL fill in 1.5 mL NexJect™ Single-dose Prefilled Syringe with Luer Lock | 2 mg/mL |
NDC 0409-1380-01 Clamshell of 10 1 mL fill in 1.5 mL NexJect™ Single-dose Prefilled Syringe with Luer Lock | 4 mg/mL |
Note that a needle is not included.
PROTECT FROM LIGHT
Keep covered in carton until time of use. Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature].